Covance, Inc. (NYSE:CVD)
A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
RTChokies
(92.95)
Submitted: 1/16/2012 10:00:11 AM :
Start Price:
$44.22
CVD Score:
+1.12
fair value is 65
Recs
HealthcareGuy
(97.83)
Submitted: 4/1/2011 4:00:57 PM :
Start Price:
$57.40
CVD Score:
-20.54
Inflection pt in CRO activity
Recs
dmk516
(< 20)
Submitted: 11/11/2010 8:34:03 PM :
Start Price:
$47.13
CVD Score:
-13.24
just looking at the chart
Recs
hybridinvestor
(51.01)
Submitted: 4/26/2010 1:30:34 PM :
Start Price:
$59.16
CVD Score:
-32.41
Top 2 (other is PPDI) CROs in the market. No debt and solid overall balance sheet. Bought PPDI when it sold off somewhat recently to low 20s and will look to add back into CVD with this CAPS pick a way for me to follow the pick more closely.
Recs
BLAYNE100
(54.15)
Submitted: 11/16/2009 8:46:42 PM :
Start Price:
$53.76
CVD Score:
-35.25
Strong Sector for 2010
Recs
wooderino
(95.76)
Submitted: 10/27/2009 12:35:38 PM :
Start Price:
$54.69
CVD Score:
-41.35
Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.
Recs
NRT104
(< 20)
Submitted: 8/9/2009 9:22:24 AM :
Start Price:
$54.72
CVD Score:
-49.64
drus will go up
Recs
hondo928
(99.66)
Submitted: 3/10/2009 4:18:50 PM :
Start Price:
$44.75
CVD Score:
-53.56
I have bull picks on all of these companies ICON, PRXL etc.
Recs
TMFBiologyFool
(97.67)
Submitted: 2/2/2009 11:34:23 PM :
Start Price:
$39.82
CVD Score:
-48.59
Pharma outsourcing will benefit CROs in the long run.
Recs
kevinottofro
(98.80)
Submitted: 1/25/2009 8:56:02 AM :
Start Price:
$33.84
CVD Score:
-27.14
Low Relative PE, good caps score, upcoming earnings not too bad decent lt growth prospects - bottom fishing.
Recs
snooperjoe
(83.51)
Submitted: 12/21/2008 11:29:26 PM :
Start Price:
$40.87
CVD Score:
-41.39
CVD is the tool that most drug companies need to employ to replenish their stable of proprietary drugs. They do not need to sell drugs, but need the demand to bring new drugs to market.
Recs
Gumfactor
(40.05)
Submitted: 12/18/2008 1:56:03 PM :
Start Price:
$41.44
CVD Score:
-41.06
Pummeled. Absolutely pummeled. From $100 to $40 this year.
But the company remains solid in every respect, and is almost guaranteed a comeback. Not to mention that the biotech sector is seeing some action as a hedge against a recession. I'm loading up on biotechs, but would probably take CVD either way.
I put it at $60 by June.
Recs
tskephart
(37.06)
Submitted: 11/26/2008 12:45:58 PM :
Start Price:
$38.16
CVD Score:
-36.86
Will benefit from pharma outsourcing
Recs
4DJTnC
(< 20)
Submitted: 11/10/2008 1:21:43 PM :
Start Price:
$46.28
CVD Score:
-49.63
FIrstly it's quite clear this one has only dropped because of the market volatility. A sector leader constantly improving on itself, as is evidenced in a number of accolades this year from its own customers. The only thumbs down below is obviously from a peta activist -- all sane writers here are thumbs up. Other than a full blown market crash, this one practically HAS to go back up. 60$ easy when the indices trend up, 80$ when recession talk dies, and 100$ a year after that.
Recs
Recs
pjani06
(54.51)
Submitted: 10/31/2008 8:51:15 PM :
Start Price:
$50.02
CVD Score:
-49.99
Worldwide drug development needed - great entry point & 71-0 outperform calls by caps all stars
Recs
epumple
(< 20)
Submitted: 6/26/2008 2:44:25 PM :
Start Price:
$82.89
CVD Score:
+49.20
Covance is notorious for its cruel treatment of its laboratory animals and is the subject
of a major campaign by Peta. Unlike most industries that use animals, Covance has
been totally resistant to negotiation on this issue. I believe this is a sign of unethical
management and expect this company to do poorly.
Recs
tcarey2000
(40.56)
Submitted: 5/19/2008 11:32:14 PM :
Start Price:
$82.42
CVD Score:
-41.73
Rise of CROs and the Downsizi g and Globilization of Big Pharma R&D.
Recs
EMG114
(20.83)
Submitted: 5/8/2008 8:27:00 PM :
Start Price:
$85.90
CVD Score:
-47.38
Good investment for the long-term...
Recs
BiLoandWise
(61.32)
Submitted: 5/5/2008 7:24:42 AM :
Start Price:
$80.93
CVD Score:
-41.74
A TMFEldrehad Monthly pick.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 39 : 1 2 Next »